EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)Open Access

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial

William J Aronson iD, Tristan Grogan iD, Pei Liang iD, Patricia Jardack, Amana R Liddell, Claudia Perez iD, David Elashoff, Jonathan Said, Pinchas Cohen iD, Leonard S Marks, Susanne M Henning iD

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco.24.00608 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von William J Aronson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Fish Oils, Fatty Acids, Omega-3, Fatty Acids, Omega-6. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Men on active surveillance (AS) for prostate cancer are extremely interested in dietary changes or supplements to prevent progression of their disease. We sought to determine whether a high omega-3, low omega-6 fatty acid diet with fish oil capsules (D + FO) decreases proliferation (Ki-67) in prostate biopsies in men with prostate cancer on AS over a 1-year time period. METHODS In this phase II, prospective randomized trial, men (N = 100) with grade group 1 or 2 prostate cancer who elected AS were randomly assigned to the D + FO or a control group. Same-site prostate biopsies were obtained at baseline and 1 year. The primary end point was the change in Ki-67 index from baseline to 1 year from same-site biopsies compared between the groups. RESULTS The Ki-67 index decreased in the D + FO group by approximately 15% from baseline to 1 year (1.34% at baseline, 1.14% at 1 year) and increased in the control group by approximately 24% from baseline to 1 year (1.23% at baseline, 1.52% at 1 year), resulting in a statistically significant difference in the change of Ki-67 index between the groups (95% CI, 2% to 52%, P = .043). There was no significant difference in the secondary outcomes grade group, tumor length, Decipher genomic score, or prostate-specific antigen between the two groups. Four patients in the D + FO group were withdrawn from the trial because of adverse events related to the FO. CONCLUSION A high omega-3, low omega-6 diet with FO for 1 year resulted in a significant reduction in Ki-67 index, a biomarker for prostate cancer progression, metastasis, and death. These findings support future phase III trials incorporating this intervention in men on AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsFish OilsFatty Acids, Omega-3Fatty Acids, Omega-6Watchful WaitingHumansMaleMiddle AgedAgedKi-67 AntigenProspective StudiesDietary SupplementsProstate-Specific AntigenCell Proliferation

Substanzen

Fish OilsFatty Acids, Omega-3Fatty Acids, Omega-6Ki-67 AntigenProstate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • VA Medical Center Greater Los Angeles Healthcare System, Los Angeles, CA.
  • Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • Clinical Translational Science Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • Department of Pathology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
  • Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA.

ORCID-Profile: William J Aronson, Tristan Grogan, Pei Liang, Claudia Perez, Pinchas Cohen, Susanne M Henning

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Aronson, W. J., Grogan, T., Liang, P., Jardack, P., Liddell, A. R., Perez, C., Elashoff, D., Said, J., Cohen, P., Marks, L. S., & Henning, S. M. (2025). High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00608

Vancouver

Aronson WJ, Grogan T, Liang P, Jardack P, Liddell AR, Perez C, et al. High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial. Journal of Clinical Oncology. 2025. doi:10.1200/jco.24.00608

BibTeX
@article{Aronson2025,
  author = {Aronson, William J and Grogan, Tristan and Liang, Pei and Jardack, Patricia and Liddell, Amana R and Perez, Claudia and Elashoff, David and Said, Jonathan and Cohen, Pinchas and Marks, Leonard S and Henning, Susanne M},
  title = {High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco.24.00608}
}
Kostenlos starten →